Also trades as: 3933.HK (HKSE) · $vol 7M

$1.07

+0.00 (+0.00%)

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 37 · $2.1B mcap · 1.12B float · 0.0000% daily turnover · Short 100% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

Income Trends

Revenue

$12.9B -6.5% ▼

5Y CAGR: +8.0%

Gross Profit

$5.4B -11.7% ▼

5Y CAGR: +7.1%

Operating Income

$2.2B -29.0% ▼

5Y CAGR: +12.4%

Net Income

$2.0B -23.6% ▼

5Y CAGR: +23.7%

EPS (Diluted)

$1.05 -28.1% ▼

5Y CAGR: +21.3%

EBITDA

$2.8B -27.8% ▼

5Y CAGR: +9.3%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$9.7B	$11.3B	$13.7B	$13.8B	$12.9B
YoY Growth	+10.6%	+16.8%	+21.2%	+0.1%	-6.5%
Cost of Revenue	$5.5B	$6.4B	$7.4B	$7.7B	$7.5B
Gross Profit	$4.2B	$5.0B	$6.3B	$6.1B	$5.4B
Gross Margin	43.4%	43.8%	46.1%	44.2%	41.7%
R&D Expenses	$465M	$594M	$757M	$891M	$897M
SG&A Expenses	$2.3B	$2.4B	$2.4B	$2.3B	$2.3B
Operating Expenses	$2.8B	$3.0B	$3.0B	$3.0B	$3.2B
Operating Income	$1.4B	$2.0B	$3.3B	$3.1B	$2.2B
Operating Margin	14.5%	17.8%	23.9%	22.6%	17.2%
Interest Expense	$60M	$82M	$67M	$35M	$68M
Income Before Tax	$1.2B	$2.0B	$3.3B	$3.3B	$2.5B
Tax Expense	$213M	$426M	$643M	$631M	$435M
Net Income	$988M	$1.6B	$2.7B	$2.7B	$2.0B
Net Margin	10.2%	13.9%	19.7%	19.3%	15.8%
EPS (Diluted)	$0.54	$0.87	$1.49	$1.46	$1.05
EBITDA	$2.0B	$2.5B	$4.0B	$3.9B	$2.8B
Shares Outstanding	1.84B	1.82B	1.82B	1.82B	1.89B

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$6.2B	$6.9B	$6.8B	$7.2B	$6.6B	$7.5B	$5.6B	$6.2B
Cost of Revenue	$3.4B	$3.7B	$3.7B	$3.8B	$3.8B	$3.6B	$4.0B	$4.0B
Gross Profit	$2.7B	$3.2B	$3.1B	$3.3B	$2.7B	$3.9B	$1.6B	$2.1B
Gross Margin	44.1%	46.5%	45.7%	46.6%	41.6%	52.2%	27.9%	34.4%
R&D Expenses	$351M	$339M	$419M	$447M	$444M	$499M	$415M	$439M
SG&A Expenses	$1.2B	$1.4B	$1.0B	$1.1B	$1.2B	$1.1B	$1.2B	$1.1B
Operating Expenses	$1.5B	$1.6B	$1.4B	$1.5B	$1.7B	$1.6B	$1.6B	$1.6B
Operating Income	$1.2B	$1.5B	$1.7B	$1.8B	$1.1B	$2.3B	-$21M	$559M
Operating Margin	18.9%	21.7%	24.6%	25.1%	16.1%	30.5%	-0.4%	9.1%
Interest Expense	$0	$0	$0	$0	$0	$0	$48M	$45M
Income Before Tax	$1.2B	$1.6B	$1.7B	$1.9B	$1.4B	$2.4B	$107M	$465M
Tax Expense	$228M	$328M	$315M	$411M	$220M	$526M	-$78M	$121M
Net Income	$952M	$1.3B	$1.4B	$1.5B	$1.2B	$1.9B	$188M	$348M
Net Margin	15.5%	18.6%	20.7%	20.8%	17.7%	25.2%	3.4%	5.6%
EPS (Diluted)	$0.52	$0.71	$0.78	$0.82	$0.64	$1.04	$0.06	$0.18
EBITDA	$1.4B	$1.8B	$1.9B	$2.0B	$1.4B	$2.5B	$312M	$969M
Shares Outstanding	1.82B	1.82B	1.82B	1.82B	1.82B	1.82B	3.00B	1.97B

ULIHF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet